Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Mina, Takahashi"'
Autor:
Tomohiro Shidahara, Shozo Ohsumi, Yuichiro Miyoshi, Mina Takahashi, Seiki Takashima, Kenjiro Aogi, Norihiro Teramoto
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Chemotherapy is often difficult to treat human epidermal growth factor receptor 2 (HER2)-positive metastatic recurrent breast cancer in the elderly, and no standard treatment has been established at this point. We experienced a case in which trastuzu
Externí odkaz:
https://doaj.org/article/674188a6bce94315b11aa61fbcff3e77
Autor:
Fumine Tsukamoto, Koji Arihiro, Mina Takahashi, Ken-ichi Ito, Shozo Ohsumi, Seiki Takashima, Takaaki Oba, Masayuki Yoshida, Kazuki Kishi, Keisuke Yamagishi, Takayuki Kinoshita
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The benefits of postoperative chemotherapy in patients with estrogen receptor (ER)-positive breast cancer remain unclear. The use of tumor grade, Ki-67, or ER expression failed to provide an accurate prognosis of the risk of relap
Externí odkaz:
https://doaj.org/article/3f42261e6f1d42f2bb5fcc6fdaaa5ceb
Autor:
Megumi Takaoka, Shozo Ohsumi, Yuichiro Miyoshi, Mina Takahashi, Seiki Takashima, Kenjiro Aogi, Teruhiko Shimizu, Norihiro Teramoto, Yasuko Yamamoto, Miki Okamura
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-5 (2021)
Abstract Background Hereditary breast and ovarian cancer (HBOC) syndrome is a susceptibility syndrome for cancers, such as breast and ovarian cancer, and BRCA1/2 are its causative genes. Annual breast-enhanced magnetic resonance imaging (MRI) is reco
Externí odkaz:
https://doaj.org/article/40509a5bfa7a41ffac779ea0f30a4b4f
Autor:
Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochiai
Publikováno v:
Cancer Research Communications.
Resistance to immune-checkpoint blockade remains challenging in patients with non-small cell lung cancer (NSCLC). Tumor-infiltrating leukocyte (TIL) quantity, composition, and activation status profoundly influence responsiveness to cancer immunother
Publikováno v:
Journal of Anesthesia.
Purpose: Although it is important to recognize gender disparities in publishing to achieve gender diversity, women's authorship in Japan remains unclear. Therefore, this study aimed to investigate the percentage and analyze the trends of articles aut
Autor:
Tomo Osako, Masaaki Matsuura, Daisuke Yotsumoto, Shin Takayama, Koji Kaneko, Mina Takahashi, Kenzo Shimazu, Katsuhide Yoshidome, Kazuya Kuraoka, Masayuki Itakura, Mayumi Tani, Takashi Ishikawa, Yasuyo Ohi, Takayuki Kinoshita, Nobuaki Sato, Masahiko Tsujimoto, Seigo Nakamura, Hitoshi Tsuda, Shinzaburo Noguchi, Futoshi Akiyama
Publikováno v:
Cancer. 128:1913-1920
Autor:
Norihiro Teramoto, Shozo Ohsumi, Tomohiro Shidahara, Seiki Takashima, Kenjiro Aogi, Yuichiro Miyoshi, Mina Takahashi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Chemotherapy is often difficult to treat human epidermal growth factor receptor 2 (HER2)-positive metastatic recurrent breast cancer in the elderly, and no standard treatment has been established at this point. We experienced a case in which trastuzu
Autor:
China, Ogura, Yoshikazu, Ogawa, Haruna, Kameoka, Kazuki, Fukuda, Mina, Takahashi, Kenjirou, Aogi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(12)
Palbociclib(PAL), which is a small molecule with inhibitory activity against cyclin-dependent kinase 4/6, is used in endocrine combined therapy for the treatment of estrogen receptor(ER)-positive and HER2-negative inoperable and recurrent breast canc
Publikováno v:
Clinical Nuclear Medicine; Nov2023, Vol. 48 Issue 11, pe529-e531, 3p
Autor:
Sachiko Kiyoto, Shozo Ohsumi, Kenjiro Aogi, Mina Takahashi, Sachie Shimizu, Seiki Takashima, Miyuki Doi
Publikováno v:
Supportive Care in Cancer
Purpose Scalp cooling during chemotherapy infusion to mitigate alopecia for breast cancer patients is becoming widespread; however, studies regarding hair recovery after chemotherapy with scalp cooling are limited. We conducted a prospective study of